← Back to Vital Edge Science
← Back to Vital Edge Science Compound Comparison Tool

How are these compounds
scientifically different?

Compare mechanisms, targets, research profiles and pharmacokinetics for up to 4 compounds side by side. This maps what is scientifically known — it does not tell you which compound to choose.

This is a scientific comparison, not a recommendation. It does not answer "which should I take?" — for potential combination-specific considerations, see the Interaction Checker; for regulatory/clinical-development history, see the Research Status Explorer.

Thymosin Beta-4 (TB-4) × GHK-Cu × 2 of 4 selected View comparison

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Remove
VS

GHK-Cu

Copper-binding tripeptide

Remove

Target & Mechanism Comparison

Primary molecular targets for each selected compound, drawn directly from each compound's structured scientific record. Not every compound has a single conventional receptor target — where that's the case, its differentiating mechanism is noted below instead.

← Scroll to see all compounds →

Target Thymosin Beta-4 (TB-4)GHK-Cu
✓ —
— ✓

What These Compounds Share

Shared research line

All selected compounds are catalogued under Rebuild.

Shared research areas
Wound models

Key Differences

Thymosin Beta-4 (TB-4) ACTIN is a direct target of Thymosin Beta-4 (TB-4) that none of the other selected compounds share. Thymosin Beta-4 -- an actin-binding peptide, mechanistically distinct from the other Rebuild-line compounds here.
GHK-Cu MMP is a direct target of GHK-Cu that none of the other selected compounds share. The only copper-complex peptide in the catalogue.

Compound Detail

Thymosin Beta-4 (TB-4)
What is it?
A naturally occurring peptide involved in how cells move and repair tissue.
What are people researching/using it for?
Studied for wound healing, tissue repair and recovery.
Other uses being trialed
Blood vessel formation researchSports recovery research
Worth knowing
Identity as Thymosin Beta-4 (rather than a shorter/unrelated fragment sold under the same commercial name) is supported by this specific product's own third-party analytical testing -- see "Current Vital Edge Testing" below and "View Research Sources" for the underlying lab reports. That analytical result confirms what's in the vial; it does not speak to the strength of the broader clinical evidence base for Thymosin Beta-4 itself, which remains predominantly preclinical with no established human administration research identified.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
Thymosin Beta-4, an actin-binding peptide researched across cell-migration, angiogenesis and tissue-repair models.
43-amino-acid peptide · 43 amino acids · Synthetic -- third-party analytical testing identifies the tested Vital Edge sample as Thymosin Beta-4 (see Current Vital Edge Testing below); this product-level analytical result is separate from evidence concerning the pharmacology or clinical effects of Thymosin Beta-4, and is not assumed from the commercial name alone
Also known as: TB-500, Tβ4, TB4
Primary Targets & Biological System
Actin biology / tissue repair

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
Thymosin Beta-4's best-characterised biochemical role is as an actin-sequestering peptide -- it binds free actin monomers inside the cell, regulating the pool available for the cytoskeleton to assemble and disassemble. This actin-regulating activity is mechanistically linked to cell migration, since cells rely on dynamic actin remodelling to move, and has made it a subject of research in angiogenesis (new blood-vessel formation) and wound/tissue-repair models where cell migration is a rate-limiting step.
Research Areas
Actin biologyCell migrationTissue repairAngiogenesisWound models
Research Profile
Human administration: None identified Preclinical: Limited
Pharmacokinetics
Not adequately established
Research Routes
Subcutaneous (research contexts) (descriptive only — not administration or dosing guidance)
Key Differentiator
Thymosin Beta-4 -- an actin-binding peptide, mechanistically distinct from the other Rebuild-line compounds here.
Considerations
Research Limitations
Identity as Thymosin Beta-4 (rather than a shorter/unrelated fragment sold under the same commercial name) is supported by this specific product's own third-party analytical testing -- see "Current Vital Edge Testing" below and "View Research Sources" for the underlying lab reports. That analytical result confirms what's in the vial; it does not speak to the strength of the broader clinical evidence base for Thymosin Beta-4 itself, which remains predominantly preclinical with no established human administration research identified.
Experimental / Off-Label Research

Not an approved or established use. These are active or emerging research directions found in the literature, shown for informational context only — not a claim that this compound is approved, effective, or safe for these purposes.

Cardiac repair after heart attack
Preclinical (animal) research has investigated Thymosin Beta-4's role in supporting heart tissue repair after myocardial infarction, tied to its actin-regulation and cell-migration mechanism. No established human cardiac-repair evidence.
Corneal / dry-eye research
A Thymosin Beta-4-based eye-drop formulation has been studied in early-phase human trials for dry eye and corneal healing -- a distinct formulation and delivery route from a research-use injectable peptide.
Availability & Sources
Current Vital Edge Testing
Available As (Vital Edge Science)
Thymosin Beta-4 (TB-4) · A$109.95 A$119.95
Browse products →
View Research Sources (2) →
Janoshik Analytical identity/purity report — Batch 1 (Task #84090)

Third-party analytical report (Janoshik) identifies the sample as "TB-500 (TB4)" with a quantified result (10.19 mg) and 99.803% purity. This is identity/purity evidence for what is in this specific product's vial, not clinical or pharmacological evidence about Thymosin Beta-4 as a molecule.

Supports: molecular_type, peptide_length, endogenous_status, canonical_name

Janoshik Analytical identity/purity report — Batch 2 (Task #104552)

Second batch, same product -- included for continuity of identity verification across batches.

Supports: molecular_type, peptide_length, endogenous_status

GHK-Cu
What is it?
A naturally occurring copper-carrying peptide involved in skin and tissue renewal.
What are people researching/using it for?
Studied for skin health, wound healing and anti-ageing skin research.
Other uses being trialed
Hair growth researchWound care research
Worth knowing
Human research is limited relative to the preclinical/in-vitro literature.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
A copper-binding tripeptide researched for roles in extracellular matrix remodelling, fibroblast biology and skin biology.
Metallopeptide complex (GHK + Cu²⁺) · 3 amino acids · Gly-His-Lys · Endogenous tripeptide complexed with copper
Primary Targets & Biological System
Extracellular matrix / dermal biology

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
A copper-binding tripeptide whose activity is thought to depend on the copper ion it carries as much as the peptide sequence itself. Research has investigated its role in extracellular matrix remodelling -- particularly regulating the balance between matrix metalloproteinases (MMPs, which break matrix down) and their inhibitors (TIMPs) -- along with broader effects on collagen production and copper-dependent cellular signalling relevant to skin and connective-tissue biology.
Research Areas
Extracellular matrixFibroblast biologyCollagenGlycosaminoglycansTissue remodellingSkin biologyWound modelsHair/cosmetic research
Research Profile
Human administration: Limited Preclinical: Extensive
Pharmacokinetics
No universal human half-life value is displayed.
Research Routes
Topical (cosmetic research), Subcutaneous (research contexts) (descriptive only — not administration or dosing guidance)
Key Differentiator
The only copper-complex peptide in the catalogue.
Considerations
Research Limitations
Human research is limited relative to the preclinical/in-vitro literature.
Experimental / Off-Label Research

Not an approved or established use. These are active or emerging research directions found in the literature, shown for informational context only — not a claim that this compound is approved, effective, or safe for these purposes.

COPD / emphysema
Gene-expression research (Genome Medicine, 2012) identified GHK as capable of reversing the gene-expression signature associated with emphysema-related lung destruction; a 2022 study reported GHK-Cu reduced cigarette-smoke-induced lung inflammation in animal models via oxidative-stress pathways. Mechanistic/preclinical research only -- no established human COPD treatment use.
Hair growth
Studied in small human trials for hair density/growth, generally in combination formulations rather than GHK-Cu alone.
Availability & Sources
Current Vital Edge Testing
Batch 2 · tested Oct 2026 · 99.979% purity, 132.70mg content Purity and Identification Endotoxin Heavy Metal
Available As (Vital Edge Science)
GHK-Cu · A$74.95 A$89.95
Browse products →
View Research Sources (2) →
The human tri-peptide GHK and tissue remodeling
Review / secondary literature · PMID 18644225

Supports: mechanism_summary, research_areas

GHK/GHK-Cu review
Review / secondary literature · PMID 26236730

Supports: mechanism_summary

Common Research Comparisons

Frequently studied groupings — not recommendations.

Browse more compounds

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Choose a compound

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Simplified for general understanding — see this compound's "How does it work?" section for the full research-level description.